Event date
  • 0.50 ACCME (All Other)
  • 0.50 ACCME (MD/DO Only)
  • 0.50 ACPE Pharmacy
  • 0.50 ANCC
Huntington’s disease (HD) is a rare, progressive, genetic disorder resulting in a breakdown of nerve cells in the brain. Many types of clinicians are involved in the patient journey because HD affects movement, behavior, memory loss, impulse control, and the ability to do the simplest self-care activities. This multimedia activity provides the collaborative care team of neurologists, psychiatrists, and allied healthcare providers with an improved understanding of the fundamentals of HD, its chronic burden, and how to treat patients accordingly. Hunting for Better Outcomes provides HCPs with an enhanced understanding of HD and tools for improving overall patient outcomes.
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in females. The presence of comorbid psychiatric disorders, including depression and anxiety, and obsessive compulsive disorder, may mitigate symptoms and delay diagnosis. The short-term effects of undiagnosed or undertreated ADHD in females presents a range of academic and social problems during childhood and adolescence. This course will provide participants an overview of current diagnostic practices and emerging treatment for ADHD in females.
  • 0.25 ACCME (All Other)
  • 0.25 ACCME (MD/DO Only)
  • 0.25 ACPE Pharmacy
  • 0.25 ANCC
Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) is a rare developmental epileptic encephalopathy caused by mutations in the CDLK5 gene. The CDKL5 gene provides instructions for making proteins essential for normal brain and neuron development. When there is a deficiency disorder, a hallmark symptom is seizures beginning at approximately 3 months of life.